In vivo experiments have validated the role of IQGAP1, demonstrating that knocking down IQGAP1 expression arrests the proliferation of low-grade glioma cells, with most cells halting in the G0/G1 phase. This evidence concerns the gene IQGAP1 and central nervous system cancer.